The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.

Latest News

Prostate MRI Study Examines Key Predictors of False-Negative and False-Positive Results
Prostate MRI Study Examines Key Predictors of False-Negative and False-Positive Results

February 17th 2025

Researchers found that patients with high PSA density have more than double the risk of false-negative findings on prostate MRI and those with low PSA density are significantly less likely to have false-positive results.

Newly FDA-Cleared AI Software Facilitates Advanced Denoising and Accelerated Scan Times for MRI
Newly FDA-Cleared AI Software Facilitates Advanced Denoising and Accelerated Scan Times for MRI

February 13th 2025

Forecasting Supply and Demand in Radiology in 2055
Forecasting Supply and Demand in Radiology in 2055

February 13th 2025

Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma

February 12th 2025

Breast MRI and Ultrasound Findings Linked to Elevated Risk of Axillary Residual Disease After Neoadjuvant Therapy
Breast MRI and Ultrasound Findings Linked to Elevated Risk of Axillary Residual Disease After Neoadjuvant Therapy

February 10th 2025

Latest CME Events & Activities

2025 GU Satellite Symposia in San Francisco

February 13-14, 2025

Register Now!

Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®

View More

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Register Now!

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

View More

Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?

View More

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

2025 International Symposium of Gastrointestinal Oncology (ISGIO)

September 12-13, 2025

Register Now!

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

View More

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®

November 12-14, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

More News

© 2025 MJH Life Sciences

All rights reserved.